Cytokines and fracture healing

Current Opinion in Orthopaedics

Volumn 12, Issue 5, 2001, Pages 403-408

  Cho, Tae Joon ^a,b   Gerstenfeld, Louis C ^a   Barnes, George L ^a   Einhorn, Thomas A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; EXTRACELLULAR MATRIX; FRACTURE; FRACTURE HEALING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034809550     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-200110000-00007     Document Type: Review

References (69)

1. Effect of enhanced macrophage function on early wound healing
2. The role of the macrophage in wound repair: A study with hydrocortisone and antimacrophage serum
3. Activation of an interleukin-1 responsive T-cell lymphoma by fixed P388D1 macrophages and an antibody against the Ag:MHC T-cell receptor
4. The biochemistry of fracture healing
5. Interleukins and tumor necrosis factor in inflammation
6. Cytokines in acute and chronic inflammation
7. Immunological mediators of wound healing and fibrosis
8. Healing of the musculoskeletal tissues
9. The cell and molecular biology of fracture healing
10. Does fracture repair recapitulate embryonic skeletal formation
11. Transforming growth factor-β in the regulation of fracture repair
12. The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2)
13. Growth factor regulation of fracture repair
14. Potential role of fibroblast growth factor in enhancement of fracture
15. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
16. SOX9 directly regulates the type-II collagen gene
17. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovarietomized rats
18. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
19. The functional block of TNF but not IL-6 prevents bone loss in ovariectomized mice
20. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity
21. Fracture healing
22. Bone and cytokines: Beyond IL-1, IL-6 and TNF-α
23. Estrogen cytokines and pathogenesis of postmenopausal osteoporosis
24. Sequential expression of bone morphologenetic protein tumor necrosis factor and their receptors in bone-forming reaction after mouse femoral marrow ablation
25. Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats
26. Cachectin and tumor necrosis factor as two sides of the same biologic coin
27. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophage exposed to permissive levels of RANK ligand
28. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways
29. Estrogen deficiency induces bone loss by enhancing T-cell production of TNFα
30. Cellular turnover at the chondro-osseous junction of growth plate cartilage analysis by serial sections at the light microscopical level
31. Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate
32. Apoptosis and proliferation of growth plate chondrocytes in rabbits
33. Chondrocyte apoptosis in endochondral ossification of chick sterna
34. TNF-α antigen expression is correlated with apoptosis (programmed cell death)
35. Apoptosis by death factor
36. Programmed removal of chondrocytes during endochondral fracture healing
37. Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha
38. Relation of OPG/OPG-L and inflammatory cytokine expression to bone formation, endochondral resorption, and bone remodeling during murine fracture healing
39. Impaired intramembranous bone formation during bone repair in the absence of TNFα signaling
40. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
41. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
42. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
43. Osteoprotegerin a novel secreted protein involved in the regulation of bone density
44. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
45. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues
46. The role of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
47. A new member of the tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function
48. Interleukin-6 an osteotropic factor
49. Increased esteoclast development after estrogen loss mediation by interleukin-6
50. Current concepts review transforming growth factor-beta and remodeling of bone
51. Altered cytokine production in the elderly
52. Immunologic aspects of osteoporosis
53. Estrogen receptor mRNA expression in callus during fracture healing in the rat calcif
54. Retinoic acid suppresses interleukin 6 production in normal human osteoblasts
55. Human myeloma cells promote the recruitment of osteoblast precursors: Mediation by interleukin-6 and soluble interleukin-6 receptor
56. Interleukin 6 plays a key role in the development of antigen-induced arthritis
57. IL-6 gene knockout mice
58. The expression of cytokine activity by fracture callus
59. TGF-β regulates interleukin-6 secretion by osteoblasts
60. Inflammatory cytokines regulate proliferation of cultured human osteoblasts
61. Regulation of osteoblast levels during bone healing
62. Regulation of prostaglandin G/H synthase-2 expression by interleukin-1 in human osteoblast-like cells
63. Interleukin-1 alpha induced cyclooxygenase-2 expression in bone-derived endothelial cells
64. Involvement of interleukin 1 and tumor necrosis factor alpha as endogenous growth factors in human osteoblastic cells
65. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells
66. Interleukin-1 beta is a potent inhibitor of bone formation in vitro
67. Effects of interleukin-1 beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes